Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.21 is 79% below its 5-year average of 1.01, near the low end of its 5-year range (0.21–4.23).
As of the fiscal period ended Tuesday, June 30, 2026. 59.37% below its 12-month average of 0.51.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.21.
QUICK RATIO (ACID-TEST)
0.21
QUICK RATIO (ACID-TEST) AVG TTM
0.51
QUICK RATIO (ACID-TEST) AVG 3Y
0.70
QUICK RATIO (ACID-TEST) AVG 5Y
1.01
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-59.37%
CURRENT VS 3Y AVG
-70.58%
CURRENT VS 5Y AVG
-79.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-93.83%
vs the sector median at left
Vivos Therapeutics, Inc.
Market Cap
$2.14M
Quick Ratio (Acid-Test)
0.21
TTM Avg
0.51
3Y Avg
0.70
5Y Avg
1.01
Market Cap
$2.13M
Quick Ratio (Acid-Test)
1.54
TTM Avg
2.65
3Y Avg
3.41
5Y Avg
4.73
Market Cap
$2.32M
Quick Ratio (Acid-Test)
12.73
TTM Avg
22.34
3Y Avg
19.49
5Y Avg
14.70
Market Cap
$2.37M
Quick Ratio (Acid-Test)
2.64
TTM Avg
2.37
3Y Avg
1.52
5Y Avg
1.27
Market Cap
$2.37M
Quick Ratio (Acid-Test)
2.14
TTM Avg
0.35
3Y Avg
1.93
5Y Avg
12.75
Market Cap
$2.38M
Quick Ratio (Acid-Test)
0.11
TTM Avg
0.75
3Y Avg
3.92
5Y Avg
2.68
Market Cap
$2.38M
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.19
3Y Avg
3.93
5Y Avg
6.93
Market Cap
$1.88M
Quick Ratio (Acid-Test)
4.85
TTM Avg
5.04
3Y Avg
6.52
5Y Avg
9.62
Market Cap
$1.88M
Quick Ratio (Acid-Test)
1.97
TTM Avg
4.42
3Y Avg
2.96
5Y Avg
3.81
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | $2.14M | 0.21 | 0.51 | 0.70 | 1.01 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | 1.54 | 2.65 | 3.41 | 4.73 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 12.73 | 22.34 | 19.49 | 14.70 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | 2.64 | 2.37 | 1.52 | 1.27 |
| Onconetix, Inc. (ONCO)vs › | $2.37M | 2.14 | 0.35 | 1.93 | 12.75 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | 0.11 | 0.75 | 3.92 | 2.68 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | 0.94 | 1.19 | 3.93 | 6.93 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | 4.85 | 5.04 | 6.52 | 9.62 |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | 1.97 | 4.42 | 2.96 | 3.81 |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | 0.48 | 2.93 | 2.61 | 1.85 |
Quick Ratio
0.21
Excludes inventory
Current Ratio
0.21
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.21 |
| 2026-03-31 | 0.27 |
| 2025-12-31 | 0.24 |
| 2025-09-30 | 0.78 |
| 2025-06-30 | 1.05 |
| 2025-03-31 | 0.77 |
| 2024-12-31 | 1.50 |
| 2024-09-30 | 1.44 |
| 2024-06-30 | 1.18 |
| 2024-03-31 | 0.45 |
| 2023-12-31 | 0.34 |
| 2023-09-30 | 0.28 |
| 2023-06-30 | 0.63 |
| 2023-03-31 | 1.09 |
| 2022-12-31 | 0.80 |
| 2022-09-30 | 1.63 |
| 2022-06-30 | 2.32 |
| 2022-03-31 | 3.15 |
| 2021-12-31 | 3.64 |
| 2021-09-30 | 4.15 |
| 2021-06-30 | 4.23 |
| 2021-03-31 | 2.29 |
| 2020-12-31 | 2.61 |
| 2020-09-30 | 0.48 |
| 2020-06-30 | 0.27 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.22 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
